Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. PLoS One. 2010 Jan 29; 5(1):e8972.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.